SEC Form D private-offering filing

AN2 Therapeutics, Inc.

Name: AN2 Therapeutics, Inc. - new SEC Form D private-offering filing, Menlo Park, CA
Published: 2026-03-25

A new SEC Form D private-offering notice from Menlo Park, CA, a $39,999,989 filer-stated offering target in Biotech. The source filing is one click away.

AN2 Therapeutics, Inc. site↗ Verified via SEC Form D

Clinical-stage biopharmaceutical company developing therapies for rare, chronic and serious infectious diseases using a boron chemistry platform

Filed 2026-03-25Filed to raise $39,999,989First money in 2026-03-10Raised so far $39,999,989HQ (as filed) Menlo Park, CASector Biotech ✓Stage (inferred) GrowthCall status Call-ready

Source linked the Form D on EDGAR↗Website verified an2therapeutics.com↗Named in the filing 12 executives & directors

Open this row on the live feed →More new filings in California →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.